Skip to main content
. 2021 Feb 24;473(7):1061–1085. doi: 10.1007/s00424-021-02536-z

Fig. 1.

Fig. 1

Main advantages and limitations of available cellular models based on cardiomyocytes and other cell types present in heart for the use in cardiotoxicity studies and new drug development